Cardiovascular imaging company Cleerly announced it raised $106 million in a Series C funding round.The round was led by Insight Partners and Battery Ventures with participation from pre-existing investors.
WHAT IT DOES
Cleerly is a digital…
Some big names in artificial intelligence have announced new healthcare partnerships, funding and implementations recently, across an array of clinical use cases. Here’s a sampling.
AI to improve cardiac MRIs
Amsterdam-based Royal Philips and Mayo Clinic…
What You Should Know:
– Cleerly, a pioneer in advanced cardiovascular imaging, has announced the successful closure of its Series C extension funding round, raising a total of $106M led by Insight Partners, with participation…
Continue Reading
What You Should Know:
– Eko Health, a pioneer in applying artificial intelligence for early detection of heart and lung diseases, today announced the issuance of a Category III Current Procedural Terminology (CPT) code by the…
Continue Reading
Coronary artery calcium (CAC) scans contain valuable information beyond the Agatston Score which is currently reported for predicting coronary heart disease (CHD) only. We examined whether new artificial intelligence (AI) applied to CAC scans…
Continue Reading
Hypertension — or high blood pressure — affects about 120 million adults in the U.S. and can lead to heart disease, stroke and chronic kidney disease. There is also a higher prevalence of hypertension…
Continue Reading
The NHS in England is to trial an AI tool that can predict patients’ risk of developing and worsening heart disease, and their risk of early death, using an electrocardiogram (ECG).
Researchers at Imperial College…
What You Should Know:
– Abbott, a global healthcare leader, has announced a new clinical trial, TEAM-HF, designed to improve outcomes for patients with worsening heart failure.
– The first-of-its-kind trial will leverage AI and Abbott’s…
Continue Reading
What You Should Know:
– In a significant step towards improving cardiovascular care, several Medicare Administrative Contractors (MACs) have granted coverage for Cleerly’s AI-enabled Quantitative Coronary Topography (AI-QCT) scans.
– The decision expands access to Cleerly’s…
Continue Reading
ASX-listed Echo IQ has obtained regulatory approval in the United States for its AI-driven solution that supports structural heart disease diagnosis.WHAT IT’S ABOUT
Two years since coming to the US, the company has now received…
